lutein has been researched along with aspirin in 4 studies
| Studies (lutein) | Trials (lutein) | Recent Studies (post-2010) (lutein) | Studies (aspirin) | Trials (aspirin) | Recent Studies (post-2010) (aspirin) |
|---|---|---|---|---|---|
| 2,770 | 267 | 1,422 | 48,947 | 6,817 | 13,778 |
| Protein | Taxonomy | lutein (IC50) | aspirin (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Bos taurus (cattle) | 0.35 | |
| Integrin beta-3 | Homo sapiens (human) | 5 | |
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 0.8252 | |
| Seed linoleate 13S-lipoxygenase-1 | Glycine max (soybean) | 1.375 | |
| Integrin alpha-IIb | Homo sapiens (human) | 5 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 2.271 | |
| Substance-P receptor | Cavia porcellus (domestic guinea pig) | 2.4 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 2.15 | |
| Urotensin-2 receptor | Rattus norvegicus (Norway rat) | 0.3 | |
| 4-aminobutyrate aminotransferase, mitochondrial | Rattus norvegicus (Norway rat) | 2.4 | |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.35 | |
| Prostaglandin G/H synthase 2 | Ovis aries (sheep) | 2.4081 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnett, NL; Bottle, SE; Fairfull-Smith, KE; Jensen, RT; Moody, TW; Rayner, CL; Ridnour, LA; Thomas, K; Tong, J; Wink, DA | 1 |
| Buring, JE; Gaziano, JM; Liu, S; Manson, JE; Pradhan, AD; Sesso, HD; Wang, L | 1 |
| Fischer, T | 1 |
2 review(s) available for lutein and aspirin
| Article | Year |
|---|---|
Ophthalmology. What you can do to protect your eyes.
Topics: Alcohol Drinking; Aspirin; Eye Injuries; Eye Protective Devices; Fibrinolytic Agents; Glaucoma; Humans; Hypertension; Lutein; Macular Degeneration | 2001 |
[Pharmacological therapy of age-related macular degeneration based on etiopathogenesis].
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Aspirin; Bosentan; Dietary Supplements; Docosahexaenoic Acids; Eicosapentaenoic Acid; Folic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infliximab; Lutein; Macular Degeneration; Melatonin; PPAR gamma; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Resveratrol; Stilbenes; Sulfonamides; Trimetazidine; Tumor Necrosis Factor-alpha; Ubiquinone; Vitamin D; Xanthophylls | 2015 |
2 other study(ies) available for lutein and aspirin
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of hybrid nitroxide-based non-steroidal anti-inflammatory drugs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antioxidants; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Nitrogen Oxides; Oxidative Stress; Reactive Oxygen Species; Structure-Activity Relationship | 2018 |
Plasma lycopene, other carotenoids, and the risk of type 2 diabetes in women.
Topics: Aged; Aspirin; beta Carotene; Carotenoids; Case-Control Studies; Cryptoxanthins; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Incidence; Logistic Models; Lutein; Lycopene; Middle Aged; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Surveys and Questionnaires; United States; Xanthophylls; Zeaxanthins | 2006 |